Description
The Framingham Scale allows to determine the risk of suffering any cardiovascular event in 10 years, assessing factors such as age, sex, blood pressure, diabetes, and smoking, assigning a score to each of them and stratifying the patient in low, medium, and high cardiovascular risk. It also allows to calculate the vascular age, which gives an estimate of the vascular damage of the patient through the variation of years between it and its chronological age.
Made for healthcare professionals.
Do not use for self-diagnosis. Seek a doctor’s advice.
Hide
Show More...
Made for healthcare professionals.
Do not use for self-diagnosis. Seek a doctor’s advice.
Screenshots
Framingham CardioRisk FAQ
-
Is Framingham CardioRisk free?
Yes, Framingham CardioRisk is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Framingham CardioRisk legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Framingham CardioRisk cost?
Framingham CardioRisk is free.
-
What is Framingham CardioRisk revenue?
To get estimated revenue of Framingham CardioRisk app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Vietnam yet.
Ratings History
Framingham CardioRisk Reviews
Store Rankings
Ranking History
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
231
|
|
Top Free
|
|
352
|
Framingham CardioRisk Installs
Last 30 days
Framingham CardioRisk Revenue
Last 30 daysFramingham CardioRisk Revenue and Downloads
Gain valuable insights into Framingham CardioRisk performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Gabriel Ernesto Martinez Canepa
- Languages
- English, Portuguese, Spanish
- Recent release
- 1.5 (11 months ago )
- Released on
- Jan 31, 2024 (11 months ago )
- Also available in
- Poland, India, Italy, South Korea, Kazakhstan, Lebanon, Mexico, Malaysia, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, Israel, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, United States, Vietnam, South Africa, Germany, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, United Arab Emirates, Dominican Republic, Algeria, Ecuador, Egypt, Spain, Finland, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.